Cognitive / Nootropic

Cerebrolysin vs Dihexa: Two Neurogenic Peptides Compared

Verdict Summary

Cerebrolysin has strong clinical evidence from European trials for stroke recovery and dementia. Dihexa is theoretically more potent for neurogenesis but has minimal human data.

Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →

At a Glance

DimensionCerebrolysinDihexa
TypePeptide mixture (porcine brain)Synthetic HGF/c-Met agonist
Human Clinical DataStrong (European trials)Minimal (preclinical)
Primary UseStroke recovery, dementia, neuroprotectionCognitive enhancement, neurogenesis
AdministrationIV or IM injectionOral or transdermal

Cerebrolysin Deep Dive

Cerebrolysin is a peptide mixture derived from porcine brain that has been used in European medicine for decades. It has clinical trial evidence for stroke recovery, Alzheimer's disease, and traumatic brain injury.

Dihexa Deep Dive

Dihexa is a synthetic HGF/c-Met agonist with extraordinary potency in animal models for neurogenesis and cognitive enhancement. Human data is extremely limited, making its safety profile poorly characterized.

How to Choose

Choose Cerebrolysin if…

  • Clinical evidence is a priority
  • You are recovering from stroke or TBI
  • Neuroprotection with established safety data is needed

Choose Dihexa if…

  • You are an experienced researcher exploring cutting-edge compounds
  • Maximum neurogenic potential is the goal
  • You accept the limited human safety data

Still Unsure?

Get a personalized recommendation

Take the 5-minute PeptidePilot quiz. Our algorithm evaluates your goals, body, and lifestyle to recommend the right peptide for you — vendor-neutral.

Frequently Asked Questions

More Comparisons